CYP24A1, cytochrome P450 family 24 subfamily A member 1, 1591
N. diseases: 171; N. variants: 39
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 20 | 54158136 | missense variant | G/A;C | snv | 6.6E-04; 8.0E-06 |
|
Nutritional and Metabolic Diseases | 0.800 | 1.000 | 8 | 2011 | 2015 | |||||||
|
0.790 | 0.400 | 20 | 54174979 | upstream gene variant | C/T | snv | 0.47 |
|
Immune System Diseases; Nervous System Diseases | 0.820 | 1.000 | 4 | 2011 | 2016 | |||||||
|
1.000 | 0.040 | 20 | 54172915 | missense variant | A/G | snv | 1.6E-04 | 1.3E-04 |
|
Nutritional and Metabolic Diseases | 0.700 | 1.000 | 3 | 2013 | 2016 | ||||||
|
0.763 | 0.200 | 20 | 54170358 | intron variant | C/T | snv | 0.46 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2018 | 2020 | |||||||
|
0.763 | 0.200 | 20 | 54170358 | intron variant | C/T | snv | 0.46 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2018 | 2020 | |||||||
|
0.807 | 0.240 | 20 | 54169534 | intron variant | T/C | snv | 0.20 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2018 | 2020 | |||||||
|
0.807 | 0.240 | 20 | 54169534 | intron variant | T/C | snv | 0.20 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2018 | 2020 | |||||||
|
0.925 | 0.120 | 20 | 54158136 | missense variant | G/A;C | snv | 6.6E-04; 8.0E-06 |
|
Nutritional and Metabolic Diseases | 0.700 | 1.000 | 2 | 2011 | 2011 | |||||||
|
0.925 | 0.120 | 20 | 54158136 | missense variant | G/A;C | snv | 6.6E-04; 8.0E-06 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 2 | 2011 | 2011 | |||||||
|
0.763 | 0.200 | 20 | 54170358 | intron variant | C/T | snv | 0.46 |
|
Digestive System Diseases; Neoplasms | 0.020 | 0.500 | 2 | 2020 | 2020 | |||||||
|
0.807 | 0.240 | 20 | 54169534 | intron variant | T/C | snv | 0.20 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2018 | 2020 | |||||||
|
0.807 | 0.240 | 20 | 54169534 | intron variant | T/C | snv | 0.20 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2020 | 2020 | |||||||
|
0.807 | 0.240 | 20 | 54169534 | intron variant | T/C | snv | 0.20 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2018 | 2020 | |||||||
|
0.790 | 0.160 | 20 | 54171474 | intron variant | A/G | snv | 0.36 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.790 | 0.160 | 20 | 54171474 | intron variant | A/G | snv | 0.36 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
0.752 | 0.200 | 20 | 54164552 | synonymous variant | C/T | snv | 0.12 | 8.9E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||
|
0.752 | 0.200 | 20 | 54164552 | synonymous variant | C/T | snv | 0.12 | 8.9E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||
|
0.752 | 0.200 | 20 | 54164552 | synonymous variant | C/T | snv | 0.12 | 8.9E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||
|
0.752 | 0.200 | 20 | 54164552 | synonymous variant | C/T | snv | 0.12 | 8.9E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||
|
0.763 | 0.240 | 20 | 54156202 | intron variant | T/A;C | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2015 | 2020 | ||||||||
|
0.763 | 0.240 | 20 | 54156202 | intron variant | T/A;C | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2015 | 2020 | ||||||||
|
0.851 | 0.280 | 20 | 54159083 | missense variant | C/A;T | snv | 4.0E-06; 4.2E-04 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.280 | 20 | 54159083 | missense variant | C/A;T | snv | 4.0E-06; 4.2E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Musculoskeletal Diseases; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.280 | 20 | 54159083 | missense variant | C/A;T | snv | 4.0E-06; 4.2E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Musculoskeletal Diseases; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.280 | 20 | 54159083 | missense variant | C/A;T | snv | 4.0E-06; 4.2E-04 |
|
Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |